Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report with emphasis on imaging features.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
entrez:
28
4
2019
pubmed:
28
4
2019
medline:
29
5
2019
Statut:
ppublish
Résumé
Primary intracranial leiomyosarcoma (LMS) is an extremely rare tumor in the central nervous system (CNS), and usually seen in immunocompromised individuals. Only a few cases of primary intracranial LMS have been documented in the literature and no study focused on their MRI findings. We reported a case of primary intracranial leiomyosarcoma in a immunocompetent patient and review its imaging features. A 20-year-old female was admitted to our hospital, complaining with nausea, weight loss and progressive headache in recent 2 years. The magnetic resonance imaging scan of the brain revealed a large well-defined extra-cerebral mass adherent to left temporal meninges. The mass was iso-intense on T1-weighted images (T1WI), lightly iso to hypointense on T2-weighted images (T2WI) and enhanced uniformly with contrast medium. The preoperative diagnosis is meningioma. A left craniotomy was performed for the complete resection of the mass. The lesion was diagnosed via surgical histopathology and immunochemistry as leiomyosarcoma. No evidence of recurrence and complications were found in the following 13 months. Primary intracranial leiomyosarcoma which has some special MR imaging features should be considered in the differential diagnosis of intracranial tumor.
Identifiants
pubmed: 31027080
doi: 10.1097/MD.0000000000015269
pii: 00005792-201904260-00031
pmc: PMC6831390
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15269Références
Childs Nerv Syst. 2009 Aug;25(8):1013-7
pubmed: 19308428
Surg Neurol Int. 2017 Nov 20;8:278
pubmed: 29279795
Int J Clin Oncol. 2011 Feb;16(1):63-6
pubmed: 20676716
Sarcoma. 2006;2006:52140
pubmed: 17496995
J Clin Oncol. 2011 May 10;29(14):e407-10
pubmed: 21357779
J Neurosurg. 2013 Aug;119(2):499-503
pubmed: 23621602
Neuroradiology. 1999 Jan;41(1):35-9
pubmed: 9987766
Pediatr Dev Pathol. 2004 Mar-Apr;7(2):198-203
pubmed: 15022062
Arch Iran Med. 2013 Oct;16(10):606-7
pubmed: 24093144
J Neurosurg Pediatr. 2012 Aug;10(2):121-5
pubmed: 22747091
Clin Neuropathol. 2011 May-Jun;30(3):154-7
pubmed: 21545778
Hum Pathol. 2002 Dec;33(12):1211-26
pubmed: 12514791
Acta Neurochir (Wien). 1996;138(12):1470-1
pubmed: 9030357
Onkologie. 2012;35(10):609-16
pubmed: 23038237
Clin Infect Dis. 2005 May 15;40(10):1521-8
pubmed: 15844077
J Neurosurg. 2000 Apr;92(4):688-92
pubmed: 10761660
Pediatr Radiol. 2004 Jun;34(6):495-8
pubmed: 15057493
J Neurooncol. 2011 Jul;103(3):785-90
pubmed: 21063896
Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):921-924
pubmed: 28748899
J Oncol Pract. 2016 Sep;12(9):827-9
pubmed: 27554524
Neurosurgery. 1999 Jan;44(1):199-202
pubmed: 9894982
Pediatr Hematol Oncol. 2005 Mar;22(2):89-101
pubmed: 15804994
Appl Immunohistochem Mol Morphol. 2004 Dec;12(4):387-91
pubmed: 15536343
World Neurosurg. 2019 Feb;122:116-122
pubmed: 30391601
Clin Neurol Neurosurg. 2018 Feb;165:76-80
pubmed: 29324399
J Pediatr Hematol Oncol. 2010 May;32(4):e144-7
pubmed: 20224440